SRPT FY 2018 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$301M+94.7% YoY

Gross Profit

$267M88.6% margin

Operating Income

-$344M-114.1% margin

Net Income

-$362M-120.2% margin

EPS (Diluted)

$-5.46

Cash Flow

Operating Cash Flow

-$389M

Free Cash Flow

-$453M

Stock-Based Comp.

$50M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$610M

Stockholders' Equity

$1.0B

Cash & Equivalents

$371M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$301M	$155M	+94.7%
Gross Profit	$267M	$147M	+81.2%
Operating Income	-$344M	-$172M	-100.2%
Net Income	-$362M	-$51M	-614.0%